EP3679141
METHODS AND COMPOSITIONS FOR INHIBITING EXPRESSION OF LDHA
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
12.10.2018EP published:
7.6.2023EP application number:
18867097.0
EPO information:
European Patent Register
Max expiry date:
11.10.2038
Title in English:
METHODS AND COMPOSITIONS FOR INHIBITING EXPRESSION OF LDHALanguage of the patent:
English
Timeline
Today
12.10.2018EP application
7.6.2023EP Publication
Owner
Name:
Novo Nordisk Health Care AGAddress:
The Circle 32/38 8058 Zürich, CH
Inventor
Name:
BROWN, Bob, D.Address:
Lexington, MA 02421, US
Name:
DUDEK, Henryk, T.Address:
Lexington, MA 02421, US
Name:
SAXENA, UtsavAddress:
Lexington, MA 02421, US
Name:
PURSELL, NatalieAddress:
Lexington, MA 02421, US
Name:
LAI, ChengAddress:
Lexington, MA 02421, US
Name:
WANG, WeiminAddress:
Lexington, MA 02421, US
Name:
STORR, RachelAddress:
Lexington, MA 02421, US
Name:
NAZEF, NaimAddress:
Lexington, MA 02421, US
Name:
KIM, BoyoungAddress:
Lexington, MA 02421, US
Priority
Number:
201762572398 PDate:
13.10.2017Country:
US
Number:
201762572403 PDate:
13.10.2017Country:
US
Number:
201862726950 PDate:
4.9.2018Country:
US
Classification
Categories:
C12N 15/113, A61K 31/713